From: The pattern and treatment outcomes for rectal cancer with concurrent locoregional recurrence and distant metastases after total mesorectal excision
Survival outcome
NED
(n = 41)
Non-NED
(n = 33)
Number of patients followed until death
11 (26.8%)
19 (57.6%)
3-year survival rate
61.8%
29.6%
Median survival time (month)
46
32